Conditions: Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Gastric Cancer
Interventions: Drug: TAS 102; Drug: Ramucirumab 10 MG/ML Intravenous Solution [CYRAMZA]
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Not yet recruiting
https://ift.tt/2N6PKT1
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
http://bit.ly/2SylJiJ
-
Publication date: Available online 22 March 2017 Source: Medical Journal Armed Forces India Author(s): S.C. Shaw, M.S. Vinod, Amit Devgan ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου